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Abstract
Background: Mycoplasma mastitis is increasingly posing significant impact on dairy industry. Although the effects
of major conventional mastitis pathogens on milk components has been widely addressed in the literature, limited
data on the effects of different Mycoplasma and Acholeplasma spp. on milk quality and quantity is available. The
aim of this study was to determine the casual relationship of Mycoplasma spp. and A. laidlawii to mastitis and
compare them to subclinical mastitis caused by conventional mastitis pathogens from a single dairy herd in
South Australia; Mycoplasma spp. and A. laidlawii were detected using PCR applied directly to milk samples. The
herd had mastitis problem with high somatic cell count and low response rate to conventional antimicrobial
therapy. A total of 288 cow-level milk samples were collected aseptically and used in this study.
Results: Conventional culture showed a predominance of coagulase-negative staphylococci, followed by coagulase-
positive staphylococci, Streptococcus spp., Enterococcus spp., E. coli, and Klebsiella spp. PCR results showed a high
prevalence of mycoplasmas (76.7%), including A. laidlawii (10.8%), M. bovis (6.2%), M. bovirhinis (5.6%), M. arginini
(2%), and (52.1%) of cows were co-infected with two or more Mycoplasma and Acholeplasma species. Mycoplasma
co-infection significantly increased somatic cell counts (SCC) similar to conventional mastitis pathogens and compared
to non-infected cows with 389.3, 550.3 and 67.3 respectively; and decreased the milk yield with 29.0, 29.9 and 34.4 l,
respectively. Mycoplasma co-infection caused significant increase in protein percentage, and significant decrease in fat
percentage and total milk solids, similar to other conventional mastitis pathogens. In contrast, changes in milk composition
and yield caused by various individual Mycoplasma species were non-significant.
Conclusions: Mycoplasma mastitis had on-farm economic consequences similar to common conventional mastitis
pathogens. Results of our study indicate that co-infection Mycoplasma mastitis caused similar effect on milk composition
to other mastitis pathogens and we hope these findings raise the awareness of the importance of their detection on
routine diagnostic panels.
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Background
The genus Mycoplasma belongs to the class Mollicutes
and is responsible for many diseases in cattle, including
respiratory disorders, arthritis, otitis media, and mastitis
[12, 23, 41]. Mycoplasma mastitis is highly resilient to
antimicrobial therapy and can be easily missed during
laboratory culture and susceptibility testing diagnostic
panels [25]. Among the 200 species of Mycoplasma dis-
covered to date, several have been reported to be involved
in bovine mastitis such as M. bovis, M. bovigenitalium, M.
californium, M. bovirhinis, M. arginini, M. dispar, M.
canadense, M. bovoculi, and Mycoplasma spp. bovine
groups 7 and F-38 [13]. Some studies have also indicated
that Acholeplasma spp. can be a milk contaminant or
non-pathogenic saprophyte [5, 27]. However, others
have reported isolation of A. laidlawii from clinical and
subclinical cases of bovine mastitis, suggesting a causal
relationship [31, 61, 63].
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In dairy herds, mycoplasmas can cause clinical, subclin-
ical or chronic mastitis [16]. M. bovis is considered the
most common pathogen among mycoplasmas [14]. The
possibility of isolating Acholeplasma spp. from mastitis
cases is not excluded [8, 31, 61, 63]. The incubation period
of Mycoplasma mastitis is 10–14 days [48], and shedding
of the causative pathogen may occur during this period
contributing to the spread of bacteria. Economic conse-
quences of Mycoplasma mastitis in cattle are due to
decreased milk production, cost of implementing control
procedures, and cost of diagnosis and treatment [39]. For
instance, the cost of M. bovis infection in cattle is more
than US$140 million annually in the United States, and
even higher losses have been reported in Europe [2].
Bacteriological culture of mycoplasmas from milk sam-
ples was once the most common method of detection.
However, this method is relatively slow often taking one to
2 weeks with potential non-growth of these bacteria due to
their fastidious culture requirements [45, 51], Mycoplasma
mastitis is usually excluded from general mastitis screening
tests due to its special growth requirements and time delay
[30]. Similarly, serological detection method is time-
consuming as antibody formation requires approximately
2 weeks [26]. Furthermore, there is a variation in the
growth requirements of different species of Mycoplasma
[20] which consequently affects disease detection, particu-
larly when Mycoplasma co-infection occurs. However,
most mastitis diagnostic investigations focus on the pre-
dominant species of mycoplasma associated with infection,
M. bovis, and disregard other causative Mollicutes [52].
Studies of clinical Mycoplasma co-infection also deserve
more attention, especially for epidemiological and treat-
ment investigations. Therefore, development of a rapid
and reliable screening diagnostic method is required
which will be capable in distinguishing between different
mycoplasma genera and species.
The association between Mycoplasma mastitis, individual
somatic cell count (SCC) and milk yield also requires clarifi-
cation. The association between conventional pathogens
causing mastitis, such as Streptococcus and Staphylococcus
spp., and elevated SCC has been previously reported [10, 19].
Mycoplasmamastitis can also affect SCC patterns [32, 47]. A
marked decrease in milk production has been estimated par-
ticularly from mastitis caused by S. agalactiae, Mycoplasma
spp. and Pasteurella spp. [62]. However, the effect of
Mycoplasma mastitis compared to conventional bacterial
pathogens on other milk composition has yet to be evalu-
ated. Furthermore, the pathogenicity of each individual
Mycoplasma spp., either as a single or co-infection, needs
to be explored.
This study had two aims. The first aim of this study
was to determine the effects of different Mycoplasma
spp. and A. laidlawii compared to conventional mastitis
pathogens on milk yield and other milk components in
cattle with high SCC (subclinical mastitis) from a single
dairy herd in South Australia with low response rate to
conventional antimicrobial therapy. The second aim was
to identify Mycoplasma spp. and A. laidlawii using novel
PCR applied directly to milk samples.
Methods
Sample collection
Milk samples were collected aseptically once from each
individual cow from a single commercial dairy farm near
Mount Gambier, South Australia. This farm had a his-
tory of repeated failure of mastitis treatment with high
SCC. Samples originated from cows aged 2–10 years in
the hospital mob or main milking mob if they had a high
SCC. Composite milk samples were collected aseptically
in sterile 50 mL tubes from each functional quarter of
individual cows (n = 288). Samples were kept on ice and
were sent immediately to the PC2 laboratory at The
University of Adelaide, Roseworthy Campus. In the
laboratory, milk samples were subjected to conventional
microbial culture using 10 μL aliquots according to
National Mastitis Council guidelines [24]. All samples
were then frozen at −20 °C for further analysis.
Milk analysis data
A database of individual cow yield production parame-
ters (yield, total milk solids, fat and protein percentage)
and SCC for sampled and non-sampled cows (the rest of
the herd’s cows that have also high and low SCC) was
obtained from herd testing information for the 4 herd
tests closest to the sampling points (n = 7609 cow data
points). SCC was performed for each milk sample using
a FOSS Fossomatic 5000 (Hillerød, Denmark), and instru-
mental milk components assay by a commercial laboratory
(NHIS, Cohuna, VIC, Australia).
DNA extraction
After thawing milk at ambient temperature, 2 mL of
each sample was centrifuged at 8000 X g for 20 min to
remove supernatant fat and excess liquid. DNA extrac-
tion was performed directly from milk using the QIAmp
DNA extraction kit (Qiagen, Germany) according to the
manufacturer’s instructions with minor modifications. In
order to increase the DNA yield, a much larger milk
sample (1 mL) was centrifuged at 5000 X g for 30 min
and the lipid layer removed. Genomic DNA concentration
was measured using Nanodrop 1000c (Thermofisher
Scientific Inc., Waltham, MA, USA) and stored at −20 °C
until further use.
PCR probes and protocol
A modified PCR protocol using four pairs of species-
specific primers previously published elsewhere was
developed (Table 1). In-vitro amplification of DNA to
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detect Mycoplasma and Acholeplasma spp. was carried
out in 25 μL volumes consisting of 0.25 μL Taq DNA
polymerase, 5 μL of 5× reaction buffer (Biolab, UK),
1 μL forward primer, 1 μL reverse primer, 1 μL of template
DNA and 16.75 μL of DEPC-treated water. Amplifications
were performed for 35 PCR cycles using the T100™
Thermal Cycler (Biorad Australia) and consisted of pre-
heating activation for 5 min at 95 °C, denaturation at 95 °C
for 30 s, and annealing at 60 °C for M. bovis and A. laidla-
wii, 55 °C for M. arginini and 64 °C for M. bovirhinis. The
final extension step was performed at 72 °C for 10 min.
The PCR products were subjected to electrophoresis in
1.5% agarose gels and visualised by staining with Gel Red.
Statistical analysis
For statistical analysis individual cows were grouped as
follows:
a. Bacteriologically analysed milk samples (all with SCC
of >250,000 cells/mL and assumed to have subclinical
mastitis, n = 288): which were positive for pure M.
bovis detection (GROUP 1, n = 11); positive for pure
A. laidlawi detection (GROUP 2, n = 28); positive for
pure M. bovirhinis detection (GROUP 3, n = 13);
positive for pure M. arginini detection (n = 6); positive
for Mycoplasma co-infection by two or more detected
species (GROUP 4, n = 119); positive for conventional
mastitis pathogens and Mycoplasma negative
(GROUP 5, n = 58), and cows with positive
Mycoplasma/Acholeplasma detection and positive
on conventional mastitis culture (GROUP 6, n = 53).
b. Milk samples not bacteriologically analysed: cows
with SCC of >250,000 cells/mL – assumed to have
subclinical mastitis but not sampled (GROUP 7,
n = 1146); and cows with SCC of ≤250,000 cells/mL
assumed to be non-affected by subclinical mastitis
‘healthy cows’, (GROUP 8, n = 6181).
Statistical analysis software (SAS) version 9.4 (Cary Inc.,
USA) was used to analyse data.
For assessment of the effect of subclinical mastitis (1)
or no subclinical mastitis (0) on SCC, herd test data
were log transformed (somatic cell score; SCS). Due to
the small number of positive detections (n = 6), the effect
of M. arginini on milk composition and yield was not
estimated.
The effect of subclinical mastitis on the test-day geo-
metric mean of SCC was estimated using LOGISTIC
REGRESSION in PROC GLIMMIX of SAS. The values
obtained by modelling for the SCS were back-transformed
to obtain the geometric mean of SCC. The effect of sub-
clinical mastitis on test-day milk production parameters
(yield, fat, protein and total milk solids) with pathogen as
fixed effect and a cow as a random effect, was estimated
using ANOVA in PROC MIXED of SAS. The effect of age
and stage of production (i.e. days in milk) were not
included in the final analysis as the preliminary model
demonstrated no significant effect. A statistical difference
of P < 0.05 was set as significant and P < 0.001 was highly
significant.
Results
Results showed that 221 of the 288 milk samples (76.7%)
collected from the dairy farm were positive for Mycoplasma
spp. and A. laidlawii. Among these, Mycoplasma co-
infection with two or more genera/species predominated
(52.1%), followed by single infections with A. laidlawii
(10.8%), M. bovis (6.2%), M. bovirhinis (5.6%), and M.
arginini (2%) (Table 2). Agarose gel electrophoresis for
PCR products revealed amplicon sizes stated in (Table 1).
Conventional culture for all milk samples, independently of
Mollucites isolation, showed a predominance of coagulase-
negative staphylococci (CoNS) (12.2%), and relatively
low occurrence of coagulase-positive staphylococci (CoPS)
(2.4%), Streptococcus spp. (2.1%), Enterococcus spp. (1.7%),
E. coli (1.4%), and Klebsiella spp. (0.4%) (Table 3).
Significant difference in test-day SCC was detected
between groups (Mycoplasma co-infection; GROUP 4,
conventional mastitis pathogens; GROUP 5, mycoplasmas
and other pathogens; GROUP 6, and not tested high SCC
cows; GROUP 7) and assumed healthy cows (low SCC;
Table 1 Oligonucleotides primers for detection of mycoplasmas and A. laidlawii identified by conventional PCR
Primers Sequencing 5′-3′ Species Targets Amplicon size (bp) Ref
Mb-F CTTGGATCAGTGGCTTCATTAGC M.bovis VspA gene 400 [1]
Mb-R GTCATCATGCGGAATTCTTGGGT
Arg-F AGAGTTTGATCCTGGCTCAGGA M. arginini 16S rRNA gene 449 [11]
Arg-R TCAACCAGGTGTTCTTTCCC
Mbv-F GCTGATAGAGAGGTCTATCG M. bovirhinis 16S rRNA gene 316 [34]
Mbv-R ATTACTCGGGCAGTCTCC
Acho-F AGCCGGACTGAGAGGTCTAC A. lailawii 16S rRNA gene 505 [11]
Acho-R TAATCCTGTTTGCTCCCCAC
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GROUP 8; P < 0.001) with 389.32, 550.26, 611, 960.7 and
67.33 SCCx103 cell/mL respectively. The Mycoplasma
co-infected cows (GROUP 4) showed significant difference
of SCC from assumed healthy cows (GROUP 8) at 376.15
SCCx103 cell/mL (P ≤ 0.05). However, no significant differ-
ence was observed between cows infected with M. bovis
(GROUP 1) and A. laidlawii (GROUP 2) in comparison
with assumed healthy cows (GROUP 8) with 255.09 and
216.14, SCCx103 cell/mL respectively (P > 0.05). Cor-
respondingly, test day milk yield was similarly affected
significantly in Mycoplasma co-infection (GROUP 4),
conventional mastitis pathogens (GROUP 5) and myco-
plasmas and conventional pathogens (GROUP 6) in com-
parison with assumed healthy cows (GROUP 8) with 29.0,
29.9, 27.9 and 34.4 l, respectively (P < 0.001). In contrast,
milk yield did not decline significantly in cows infected
with M. bovis (GROUP 1), A. laidlawii (GROUP 2), or
M. bovirhinis (GROUP 3) with 32.4, 32.4 and 30.0 l/day,
respectively (P > 0.05).
Fat percentage was significantly decreased in cows
co-infected with Mycoplasma (GROUP 4) with 3.1%
(P < 0.01), while no differences were observed in all
other tested groups with 3.4, 3.3, 3.3, 3.2 and 3.3% for
groups M. bovis (GROUP 1), A. laidlawii (GROUP 2),
M. bovirhinis (GROUP 3), conventional mastitis patho-
gens (GROUP 5) and mixed Mycoplasma/Acholeplasma
and conventional mastitis culture (GROUP 6) respectively
(P > 0.05). Protein percentage increased significantly in cows
with Mycoplasma co-infection (GROUP 4), conventional
mastitis pathogens (GROUP 5), mixedMycoplasma/Achole-
plasma and conventional mastitis culture (GROUP 6) and
non-tested high SCC (GROUP 7) in comparison with cows
assumed to be healthy (GROUP 8) with 3.4, 3.3, 3.4, 3.4
and 3.3%, respectively (P < 0.05), while other Mycoplasma
groups showed no differences being 3.4, 3.4 and 3.3% for
GROUPs s 1, 2 and 3 respectively (P > 0.05). In comparison,
total milk solids decreased significantly in GROUPs 4, 5, 6
and 7 in comparison to GROUP 8 with 1.8, 1.9, 1.8, 2.0 and
2.2%, respectively (P < 0.001). However, there were no
differences in total milk solids for GROUPs 1, 2 and 3
with 2.1, 2.1 and 2.0%, respectively (P > 0.05) (Table 4).
Discussion
Results showed a high prevalence of Mycoplasma and
Acoleplasma species isolated from the purposive sampled
cows. In addition, Mycoplasma co-infection significantly
changed milk quality and quantity, similarly to other
mastitis pathogens. Details on the results of culture and
PCR, including test characteristics, were not subject of
this study and are not further detailed.
The study farm had a history of mastitis treatment failure
and high SCC. The long persistence of this problem may be
due to the variety of transmission methods, such as via
direct contact, milking machines and other fomites [29].
Intermittent shedding of the pathogen from cows suffering
chronic mastitis may be another important reason for the
relatively high prevalence of Mycoplasma mastitis in the
studied herd. Chronic mastitis results from the capability of
Mycoplasma spp. to form multiple micro-abscesses within
the infected mammary gland [28]. Due to the high occur-
rence of mastitis, the studied farm is not representative of
the South Australian dairy cattle population. As the primary
objective of this study was not to carry out an epidemio-
logical investigation, but to purposively sample and collect
a significant number of isolates for research, the validity of
the study is not decreased. In addition, study results may
raise awareness of the importance of Mycoplasma mastitis
to the dairy industry. In order to establish the prevalence of
this disease in Australia, further attempts in affected herds
using methodology similar to that described in this study
are required. It is possible that the PCR technique used in
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this study detects foreign pieces of DNA. To ensure validity
of our results we also carried out conventional culture
for Mycoplasma (data not shown). Indeed, some culture-
negative samples yielded positive PCR. To ensure that we
were detecting Mycoplasma spp. and A. laidlawii, 16S
rRNA sequencing was also carried out (data not shown).
Results of this study highlight the tendency of Myco-
plasma co-infection to cause a significant alteration in milk
composition in comparison to any individual Mycoplasma
spp. group. This seems to be a result of developing evi-
dence for pathogenicity of Mycoplasma co-infection
[17], and can be a reflection of the advanced stage of
the disease. It is often thought that the mechanism of
milk alteration is attributed to the pathogen severity,
proportion of involved mammary glands alveoli, inter-
ference with blood or hormonal nourishment to these
alveoli, epithelial integrity disruption, and milk decom-
position due to enzymatic activity.
Differences between the effects of each individual
Mycoplasma spp. and A. laidlawii on milk composition in
this study is noteworthy. It has been reported worldwide
thatM. bovis is the primary contagious pathogen in bovine
Mycoplasma mastitis [14, 35, 39, 43]. In our study, cows
infected only with M. bovis (GROUP 1) showed no signifi-
cant impacts on milk composition apart from the SCC.
Cows in this group may have been at an early stage of the
disease. In addition, the limited sample size of this group
(n = 11) needs to be considered. However, the effect of
M. bovis was significant when it contributed to the
Mycoplasma co-infection group. Multiple Mycoplasma
spp. infection tends to be more common in Mycoplasma-
associated diseases [59]. Although, some studies indicate
the possibility of A. laidlawii being involves in mastitis
cases [8, 31, 63], our data showed no effect on milk
composition as an individual pathogen, being similar to
common veterinary literature that establishes these bacteria
as a milk contaminant [4, 27, 40]. We considered increased
SCC and decreased milk production in affected cows as a
crucial factor confirming the contribution of Mycoplasma
in bovine mastitis.
M. arginini was another species detected in this study.
However, we excluded it from the comparison as an
individual group due to the limited number of detection
in milk samples (n = 6). M. arginini has been reported
elsewhere with no significant impact on milk compos-
ition, but can be considered a predisposing agent to
Str. dysagalactiae leading to severe mammary gland
inflammation [58]. It is important to consider that M.
arginini is associated with some diseases in human
[56, 64]. Evidence of transmission of M. arginini to
human through bovine milk is available as it has been
isolated from blood of a man with a history of milk
product consumption who had eosinophilic ascites for
2 years [57]. M. bovirhinis (GROUP 3) showed remarkable
effect on SCC and milk yield in our study. M. bovirhinis
was first isolated in mastitis cows in England [21] and
named by Leach [37]. These bacteria showed predominance
to other mycoplasmas in some mastitis studies [22, 50].
SCC can be elevated in cows inoculated experimentally
with four different strains of M. bovirhinis causing subclin-
ical mastitis [6]. However, the study of Brownlie et al. [6]
lacks information on other milk composition changes.
Somatic cells mainly include macrophages, lymphocytes,
polymorphonuclear and epithelial cells [44]. The elevation
of these cells in bovine quarters reflects the possibility of
infection and is the standard method to discriminate
between healthy and mastitic cows [7, 42, 46, 54]. The
acceptable limit of individual cow SCC in raw milk in
Australia has been established at 250,000 cell/mL [9].
Elevated SCC appears to be an immune response to
mastitis caused by Mycoplasma, often followed by
spontaneous recovery [15]. The negative correlation be-
tween high SCC and low milk production has been widely
accepted for mastitis cases. In this study, low milk yield
Table 4 The mean values (± SE) of SCC, milk yield, milk fat, protein and total solids for dairy cattle infected with Mycoplasma and
other mastitis pathogens (in individual cow-testing points)










Tested 1 Mycoplasma bovis 11 32.4 ± 3.73 3.4 ± 0.26 3.4 ± 0.09 2.1 ± 0.20 255.1 ± 140.07
2 Acholeplasma laidlawii 28 32.4 ± 2.33 3.3 ± 0.16 3.4 ± 0.06 2.1 ± 0.13 216.1 ± 87.79
3 M. bovirhinis 13 30.0 ± 3.43a 3.3 ± 0.24 3.3 ± 0.09 2.0 ± 0.19 376.2 ± 128.85a
4 Mycoplasma co-infection 119 29.0 ± 1.13A 3.1 ± 0.08a 3.4 ± 0.03A 1.9 ± 0.06A 389.3 ± 42.58A
5 Conventional mastitis pathogens 58 29.9 ± 1.57a 3.2 ± 0.11 3.3 ± 0.04a 1.9 ± 0.09A 550.3 ± 59.00A
6 Mycoplasmas and conventional pathogens 53 27.9 ± 1.79A 3.3 ± 0.12 3.4 ± 0.04A 1.8 ± 0.11A 611 ± 12.08A
Total 282 (3.7%)
Non tested 7 High SCC 1146 29.2 ± 0.36A 3.6 ± 0.02A 3.4 ± 0.01A 2.0 ± 0.02A 960.7 ± 13.72A
8 Low SCC 6181 34.4 ± 0.15 3.4 ± 0.01 3.3 ± 0.00 2.2 ± 0.01 67.3 ± 5.90
Total 7327 (96.3%)
Lower case superscripts indicate statistical difference within column of P < 0.05 or capital superscripts indicate statistical difference within column of P < 0.001
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also appeared to be associated with positive Mycoplasma
infection which in turn was consistently associated with
higher SCC, confirming the economic impact of mastitis
caused by Mycoplasma mastitis. This decline in milk yield
can be attributed to reduction of synthesis ability of the
secretory mammary tissue [53].
The role of Mycoplasma mastitis in declining milk fat
percentage during mastitis has not been established as
yet. For other mastitis causing pathogens, contradictory
results have been stated for both elevation [46, 55] and
depression of milk fat percentage [3, 33, 53]. The decline
in fat percentage seems to be a result of leukocyte inges-
tion to fat globule [49] or due to a decrease in the synthesis
and secretion activities of mammary glands [36]. It is also
important to note that variation of fat percentage can also
affected by stage of lactation, genetics, management, nutri-
tion and hormonal changes [38]. This most likely explains
the elevation of fat percentage in the non-tested high SCC
(GROUP 7) in this study. Our results show that milk
protein percentage can be elevated significantly during
mastitis caused by Mycoplasma co-infection (GROUP 5) or
other non-Mycoplasma pathogens (GROUP 6). It is gener-
ally thought that milk proteins increase during mastitis due
to increases in blood albumins and immunoglobulins influx
as an immune response [3, 18]. Protein percentage
increases have been reported during M. agalactiae
experimental mastitis in small ruminant [60].
Decreases in total milk solids were tested to allow
farmers, practitioners and scientists who deal with mastitis
to directly compare effects of Mycoplasma infection on
milk yield to each other and to other mastitis pathogens.
SCC are usually available only at herd testing level, while
total milk solids can be detected daily by in-line milk me-
ters on some farms. Hence, the effect of different mastitis
pathogens on total milk solids tends to be more important
than SCC records to the current dairy industry. We are
aware that SCC are more sensitive to detecting early
intramammary infections. With time, in-line SCC mea-
sures may be available on many farms, and the importance
of total milk solids may not be as high as at this stage.
Data on decreases of total milk solids will also allow for
further research into economic effects of Mycoplasma
mastitis to a particular dairy herd or to the entire dairy
industry.
Effects on milk production and SCC detected in our
study may vary between farms and this should be an
area of future research.
Conclusions
In summary, we report bovine milk composition alteration
during Mycoplasma mastitis. In addition, effects of Myco-
plasma mastitis were compared with conventional mastitis
pathogens. Results of our study indicate that co-infection
Mycoplasma mastitis (GROUP 4) caused similar effect on
milk composition to other conventional mastitis pathogens
(GROUP 5), and we hope these findings raise the aware-
ness of the importance of their detection on routine
diagnostic panels. Ignoring timely detection may lead to
developing Mycoplasma co-infection which may result in
severe alterations in milk composition. However, roles of
each individual Mycoplasma spp. in mastitis economics,
and produced milk quantity and quality, needs further
investigations, particularly when present as co-infections.
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